About this trial
In order to provide treatment in pediatric hematology-oncology patients, in some cases a central venous catheter is required in children. The most important situation to pay attention to when using a central venous catheter is "Central line-associated bloodstream infections".
These infections are infections that develop after admission to the hospital and are not in the incubation period at the time of admission, or although they usually develop in the hospital 48-72 hours after hospitalization, they can sometimes appear after discharge. Central line-associated bloodstream infections significantly increase morbidity and mortality. In this context, the effect of using a care bundle containing chlorhexidine dressing on port catheter and central venous catheter-related bloodstream infections in pediatric cancer patients was examined.
Eligibility criteria
Qualifiers
The child is receiving inpatient treatment at the Hematology and Oncology unit and hematopoietic stem cell transplantation unit
The child has a diagnosis of hematological or oncological cancer
The child's age range is between 1 and 17
Having a port catheter inserted and no early complications have occurred
Disqualifiers
Have a systemic infection.
Trial design
Treatments tested in this trial
- Chlorhexidine Dressing
Treatment groups
Sponsors and collaborators
Dokuz Eylul University
Lead sponsor
Afyonkarahisar Health Science University
Collaborator